Montclair, NJ, United States of America

Michael B Mathews

USPTO Granted Patents = 13 

Average Co-Inventor Count = 4.5

ph-index = 8

Forward Citations = 213(Granted Patents)


Location History:

  • Cold Spring Harbor, NY (US) (1998)
  • Montclair, NJ (US) (2000 - 2017)

Company Filing History:


Years Active: 1998-2017

Loading Chart...
13 patents (USPTO):Explore Patents

Title: **Inventor Spotlight: Michael B. Mathews**

Introduction

Michael B. Mathews is a prolific inventor based in Montclair, NJ, known for his contributions to the field of molecular biology. With a total of 13 patents to his name, Mathews has made significant strides in understanding and manipulating the processes involved in mRNA decay, leading to potential advancements in therapeutic treatments.

Latest Patents

Among his latest patents, Mathews has developed novel methods for treating Nonsense-Mediated Decay (NMD) through the inhibition of eukaryotic initiation factor 5A (eIF5A). One significant patent outlines an approach for inhibiting nonsense-mediated mRNA decay by administering a composition that prevents hypusination of eIF5A. This treatment aims to enhance gene expression of NMD-susceptible mRNA, thus mitigating the degradation typically caused by NMD.

Another critical patent focuses on the administration of an inhibitor of NMD along with a nonsense suppressor to patients suffering from NMD. This innovative method aims to block translation termination at misplaced nonsense codons, offering a promising avenue for therapeutic development in related diseases.

Career Highlights

Mathews has had an impactful career, working with industry-leading organizations such as Rigel Pharmaceuticals and Rutgers, the State University of New Jersey. His role in these institutions has been instrumental in advancing research into mRNA processes and developing innovative treatment methodologies.

Collaborations

Throughout his career, Mathews has collaborated with esteemed colleagues in the field, including Michael G. Katze and Julia C. Watson. These partnerships have bolstered his research efforts and led to significant breakthroughs in understanding the complexities of gene expression and mRNA stability.

Conclusion

Michael B. Mathews exemplifies the spirit of innovation in the scientific community. His work on patents addressing mRNA decay mechanisms demonstrates the potential for new treatments that could change the landscape of therapeutic interventions. As he continues to develop his research, the impact of his innovations will undoubtedly benefit many in the medical field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…